Vaxcyte, Inc.

NasdaqGS:PCVX Stock Report

Market Cap: US$10.7b

Vaxcyte Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Grant Pickering

Chief executive officer

US$12.1m

Total compensation

CEO salary percentage5.3%
CEO tenure11yrs
CEO ownership0.5%
Management average tenure4.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy

Sep 06

We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Aug 24
We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

May 10
Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Dec 27
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Sep 12
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

May 30
Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Dec 22
We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Vaxcyte appoints new CBO, CMO

Oct 11

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Aug 05
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate

Jul 12

CEO Compensation Analysis

How has Grant Pickering's remuneration changed compared to Vaxcyte's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$508m

Jun 30 2024n/an/a

-US$497m

Mar 31 2024n/an/a

-US$437m

Dec 31 2023US$12mUS$640k

-US$402m

Sep 30 2023n/an/a

-US$300m

Jun 30 2023n/an/a

-US$265m

Mar 31 2023n/an/a

-US$245m

Dec 31 2022US$14mUS$601k

-US$223m

Sep 30 2022n/an/a

-US$174m

Jun 30 2022n/an/a

-US$143m

Mar 31 2022n/an/a

-US$118m

Dec 31 2021US$5mUS$575k

-US$100m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$87m

Mar 31 2021n/an/a

-US$83m

Dec 31 2020US$3mUS$481k

-US$89m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$73m

Mar 31 2020n/an/a

-US$64m

Dec 31 2019US$596kUS$426k

-US$50m

Compensation vs Market: Grant's total compensation ($USD12.14M) is about average for companies of similar size in the US market ($USD12.73M).

Compensation vs Earnings: Grant's compensation has been consistent with company performance over the past year.

CEO

Grant Pickering (56 yo)

11yrs

Tenure

US$12,135,683

Compensation

Mr. Grant E. Pickering, M.B.A., is Co-Founder of Vaxcyte, Inc. since 2013 and has been its Chief Executive Officer and Director since November 2013 and served as its President since November 2013 until Dec...

Leadership Team

NamePositionTenureCompensationOwnership
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 56.9m
Andrew Guggenhime
President & CFO4.5yrsUS$5.42m0.059%
$ 6.4m
James Wassil
Executive VP & COO4.9yrsUS$5.40m0.14%
$ 14.9m
Mikhail Eydelman
Senior VP2.6yrsUS$3.49m0.0081%
$ 870.0k
Ashish Khanna
Co-Founder11.8yrsno datano data
Jeff Fairman
Co-Founder & VP of Researchno datano datano data
Elvia Cowan
Senior VP of Finance & Principal Accounting Officer1.8yrsno data0.0031%
$ 335.3k
Janet Graesser
Senior Vice President of Corporate Communications & Investor Relationsno datano datano data
Whitney Jones
Chief People Officerless than a yearno datano data
Paul Sauer
Senior Vice President of Process Development & Manufacturing8.6yrsUS$2.35mno data
Harp Dhaliwal
Senior Vice President of Commercial Manufacturing & Supply Chain3yrsUS$1.84mno data
Sam Iki
Senior Vice President of Project Managementno datano datano data

4.5yrs

Average Tenure

55yo

Average Age

Experienced Management: PCVX's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 56.9m
Annie Drapeau
Independent Director3.2yrsUS$704.22k0.0045%
$ 483.2k
K. Hirth
Independent Director8.2yrsUS$696.72k0.010%
$ 1.1m
Heath Lukatch
Independent Director6.5yrsUS$691.72k0.0045%
$ 483.2k
Halley Gilbert
Independent Director4.6yrsUS$704.22k0.0045%
$ 483.2k
Emmanuel Walter
Member of Scientific Advisory Boardno datano datano data
Carlos Paya
Independent Chairman of the Board3.1yrsUS$724.22k0.0045%
$ 483.2k
Anthony Ford-Hutchinson
Member of Scientific Advisory Boardno datano datano data
Jeffrey Almond
Member of Scientific Advisory Board7.8yrsno datano data
Teri Loxam
Independent Director3.2yrsUS$704.22k0.0045%
$ 483.2k
Emmanuel Hanon
Member of Scientific Advisory Boardno datano datano data
William Hausdorff
Member of Scientific Advisory Boardno datano datano data

5.5yrs

Average Tenure

57yo

Average Age

Experienced Board: PCVX's board of directors are considered experienced (5.5 years average tenure).